JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB235550

Miransertib, pan-Akt inhibitor

Be the first to review this product! Submit a review

|

(2 Publications)

MW 432.5 Da, Purity >98%. Allosteric, selective, non-ATP competitive pan-Akt inhibitor (IC50 = 5.0, 4.5, and 16 nM for Akt1, Akt2, and Akt3, respectively). Selective for Akt isoforms over a panel of 303 other kinases. Binds to and inhibits the activity of AKT in a non-ATP competitive manner, which may result in the inhibition of the PI3K/AKT signaling pathway. Orally bioavailable.

Key facts

CAS number

1313881-70-7

Purity

>98%

Form

Solid

form

Molecular weight

432.5 Da

Molecular formula

C<sub>2</sub><sub>7</sub>H<sub>2</sub><sub>4</sub>N<sub>6</sub>

PubChem

53262401

Nature

Synthetic

Solubility

Soluble in DMSO to 159.92 mM

Soluble in ethanol to 8.52 mM

Biochemical name

Miransertib

Biological description

Allosteric, selective, non-ATP competitive pan-Akt inhibitor (IC50 = 5.0, 4.5, and 16 nM for Akt1, Akt2, and Akt3, respectively). Selective for Akt isoforms over a panel of 303 other kinases. Binds to and inhibits the activity of AKT in a non-ATP competitive manner, which may result in the inhibition of the PI3K/AKT signaling pathway. Orally bioavailable.

Canonical smiles

C1CC(C1)(C2=CC=C(C=C2)N3C4=C(C=CC(=N4)C5=CC=CC=C5)N=C3C6=C(N=CC=C6)N)N

InChi

InChI=1S/C27H24N6/c28-24-21(8-4-17-30-24)25-32-23-14-13-22(18-6-2-1-3-7-18)31-26(23)33(25)20-11-9-19(10-12-20)27(29)15-5-16-27/h1-4,6-14,17H,5,15-16,29H2,(H2,28,30)

InChiKey

HNFMVVHMKGFCMB-UHFFFAOYSA-N

IUPAC Name

3-[3-[4-(1-aminocyclobutyl)phenyl]-5-phenylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine

Product details

This product is manufactured by BioVision, an Abcam company and was previously called B1931 Miransertib. B1931-25 is the same size as the 25 mg size of ab235550.

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store in the dark|Store under desiccating conditions

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Antioxidants (Basel, Switzerland) 13: PubMed39456511

2024

α-Terpineol Induces Shelterin Components TRF1 and TRF2 to Mitigate Senescence and Telomere Integrity Loss via A Telomerase-Independent Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Marianna Kapetanou,Sophia Athanasopoulou,Andreas Goutas,Dimitra Makatsori,Varvara Trachana,Efstathios Gonos

Frontiers in cardiovascular medicine 9:929030 PubMed35845066

2022

Transcriptomic and ChIP-seq Integrative Analysis Identifies KDM5A-Target Genes in Cardiac Fibroblasts.

Applications

Unspecified application

Species

Unspecified reactive species

Yiyao Jiang,Xu Zhang,Ting Wei,Xianjie Qi,Isah Amir Abba,Nana Zhang,Yao Chen,Ran Wang,Chao Shi
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com